These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 32391376)
1. Deubiquitinase Inhibitor b-AP15 Attenuated LPS-Induced Inflammation via Inhibiting ERK1/2, JNK, and NF-Kappa B. Zhang F; Xu R; Chai R; Xu Q; Liu M; Chen X; Chen X; Kong T; Zhang C; Liu SM; Zhang Z; Liu N Front Mol Biosci; 2020; 7():49. PubMed ID: 32391376 [TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-specific protease 14 regulates LPS-induced inflammation by increasing ERK1/2 phosphorylation and NF-κB activation. Liu N; Kong T; Chen X; Hu H; Gu H; Liu S; Chen X; Yang Q; Li A; Xiong X; Zhang Z Mol Cell Biochem; 2017 Jul; 431(1-2):87-96. PubMed ID: 28364380 [TBL] [Abstract][Full Text] [Related]
3. Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells. Chitta K; Paulus A; Akhtar S; Blake MK; Caulfield TR; Novak AJ; Ansell SM; Advani P; Ailawadhi S; Sher T; Linder S; Chanan-Khan A Br J Haematol; 2015 May; 169(3):377-90. PubMed ID: 25691154 [TBL] [Abstract][Full Text] [Related]
4. Targeting proteasomal deubiquitinases USP14 and UCHL5 with b-AP15 reduces 5-fluorouracil resistance in colorectal cancer cells. Ding W; Wang JX; Wu JZ; Liu AC; Jiang LL; Zhang HC; Meng Y; Liu BY; Peng GJ; Lou EZ; Mao Q; Zhou H; Tang DL; Chen X; Liu JB; Shi XP Acta Pharmacol Sin; 2023 Dec; 44(12):2537-2548. PubMed ID: 37528233 [TBL] [Abstract][Full Text] [Related]
5. Induction of tumor cell apoptosis by a proteasome deubiquitinase inhibitor is associated with oxidative stress. Brnjic S; Mazurkiewicz M; Fryknäs M; Sun C; Zhang X; Larsson R; D'Arcy P; Linder S Antioxid Redox Signal; 2014 Dec; 21(17):2271-85. PubMed ID: 24011031 [TBL] [Abstract][Full Text] [Related]
6. Deubiquitinase inhibitor b-AP15 activates endoplasmic reticulum (ER) stress and inhibits Wnt/Notch1 signaling pathway leading to the reduction of cell survival in hepatocellular carcinoma cells. Ding Y; Chen X; Wang B; Yu B; Ge J Eur J Pharmacol; 2018 Apr; 825():10-18. PubMed ID: 29454609 [TBL] [Abstract][Full Text] [Related]
7. Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15. Mofers A; Perego P; Selvaraju K; Gatti L; Gullbo J; Linder S; D'Arcy P PLoS One; 2019; 14(10):e0223807. PubMed ID: 31639138 [TBL] [Abstract][Full Text] [Related]
8. Euscaphic acid isolated from roots of Rosa rugosa inhibits LPS-induced inflammatory responses via TLR4-mediated NF-κB inactivation in RAW 264.7 macrophages. Kim IT; Ryu S; Shin JS; Choi JH; Park HJ; Lee KT J Cell Biochem; 2012 Jun; 113(6):1936-46. PubMed ID: 22234926 [TBL] [Abstract][Full Text] [Related]
9. Xanthii fructus inhibits inflammatory responses in LPS-stimulated RAW 264.7 macrophages through suppressing NF-κB and JNK/p38 MAPK. Yeom M; Kim JH; Min JH; Hwang MK; Jung HS; Sohn Y J Ethnopharmacol; 2015 Dec; 176():394-401. PubMed ID: 26560439 [TBL] [Abstract][Full Text] [Related]
10. Plumbagin inhibits LPS-induced inflammation through the inactivation of the nuclear factor-kappa B and mitogen activated protein kinase signaling pathways in RAW 264.7 cells. Wang T; Wu F; Jin Z; Zhai Z; Wang Y; Tu B; Yan W; Tang T Food Chem Toxicol; 2014 Feb; 64():177-83. PubMed ID: 24296134 [TBL] [Abstract][Full Text] [Related]
11. 4-methoxycinnamyl p-coumarate isolated from Etlingera pavieana rhizomes inhibits inflammatory response via suppression of NF-κB, Akt and AP-1 signaling in LPS-stimulated RAW 264.7 macrophages. Mankhong S; Iawsipo P; Srisook E; Srisook K Phytomedicine; 2019 Feb; 54():89-97. PubMed ID: 30668386 [TBL] [Abstract][Full Text] [Related]
12. The 19S Deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death. Wang X; Stafford W; Mazurkiewicz M; Fryknäs M; Brjnic S; Zhang X; Gullbo J; Larsson R; Arnér ES; D'Arcy P; Linder S Mol Pharmacol; 2014 Jun; 85(6):932-45. PubMed ID: 24714215 [TBL] [Abstract][Full Text] [Related]
13. A novel deubiquitinase inhibitor b-AP15 triggers apoptosis in both androgen receptor-dependent and -independent prostate cancers. Cai J; Xia X; Liao Y; Liu N; Guo Z; Chen J; Yang L; Long H; Yang Q; Zhang X; Xiao L; Wang X; Huang H; Liu J Oncotarget; 2017 Sep; 8(38):63232-63246. PubMed ID: 28968984 [TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines. Weiss T; Shalit I; Blau H; Werber S; Halperin D; Levitov A; Fabian I Antimicrob Agents Chemother; 2004 Jun; 48(6):1974-82. PubMed ID: 15155187 [TBL] [Abstract][Full Text] [Related]
15. TLR2 regulates allergic airway inflammation through NF-κB and MAPK signaling pathways in asthmatic mice. Ma SQ; Wei HL; Zhang X Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3138-3146. PubMed ID: 29863259 [TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effect of Acalypha australis L. via suppression of NF-κB signaling in LPS-stimulated RAW 264.7 macrophages and LPS-induced septic mice. Kim HJ; Joe HI; Zhang Z; Woo Lee S; Lee KY; Kook YB; An HJ Mol Immunol; 2020 Mar; 119():123-131. PubMed ID: 32014631 [TBL] [Abstract][Full Text] [Related]
17. Degraded λ-carrageenan activates NF-κB and AP-1 pathways in macrophages and enhances LPS-induced TNF-α secretion through AP-1. Chen H; Wang F; Mao H; Yan X Biochim Biophys Acta; 2014 Jul; 1840(7):2162-70. PubMed ID: 24641824 [TBL] [Abstract][Full Text] [Related]
18. Stauntoside B inhibits macrophage activation by inhibiting NF-κB and ERK MAPK signalling. Liu J; Tang J; Zuo Y; Yu Y; Luo P; Yao X; Dong Y; Wang P; Liu L; Zhou H Pharmacol Res; 2016 Sep; 111():303-315. PubMed ID: 27343699 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive Target Screening and Cellular Profiling of the Cancer-Active Compound b-AP15 Indicate Abrogation of Protein Homeostasis and Organelle Dysfunction as the Primary Mechanism of Action. Gubat J; Selvaraju K; Sjöstrand L; Kumar Singh D; Turkina MV; Schmierer B; Sabatier P; Zubarev RA; Linder S; D'Arcy P Front Oncol; 2022; 12():852980. PubMed ID: 35530310 [TBL] [Abstract][Full Text] [Related]